Glucocorticoid-induced osteopenia in the mouse as assessed by histomorphometry, microcomputed tomography, and biochemical markers

Bone

Volumn 30, Issue 6, 2002, Pages 924-930

  McLaughlin, F ^a   Mackintosh, J ^a   Hayes, B P ^a   McLaren, A ^a   Uings, I J ^a   Salmon, P ^b   Humphreys, J ^b   Meldrum, E ^a   Farrow, S N ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

^b RICARDO UK LTD   (United Kingdom)

Author keywords

Glucocorticoid; Histomorphometry; Microcomputed tomography (micro CT); Mouse; Osteoblast; Osteoporosis

Indexed keywords

BIOCHEMICAL MARKER; DEXAMETHASONE; GLUCOCORTICOID; LEPTIN; OSTEOCALCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE ATROPHY; BONE MASS; COMPUTER ASSISTED TOMOGRAPHY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE MODEL; FEMALE; FEMUR; MORPHOMETRICS; MOUSE; NONHUMAN; OSSIFICATION; OSTEOPENIA; OSTEOPOROSIS; PROTEIN BLOOD LEVEL; REGULATORY MECHANISM; TRABECULAR BONE; TRABECULAR MESHWORK;

ANIMALS; BIOLOGICAL MARKERS; BONE DISEASES, METABOLIC; DISEASE MODELS, ANIMAL; FEMALE; FEMUR; GLUCOCORTICOIDS; MICE; MICE, INBRED BALB C; MICROCOMPUTERS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0036274235     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(02)00737-8     Document Type: Article

References (46)

1. The localization of the functional human glucocorticoid receptor alpha in human bone
2. Interactions between growth hormone and dexamethasone in skeletal growth and bone structure of the young mouse
3. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification
4. Inhaled and nasal corticosteroids: Factors affecting the risks of systemic adverse effects
5. Glucocorticoids act within minutes to inhibit recruitment of signalling factors to activated EGF receptors through a receptor-dependent, transcription-independent mechanism
6. Pluripotential marrow cells produce adipocytes when transplanted into steroid-treated mice
7. Glucocorticoids repress NF-κB-driven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cell
8. Induction of ob gene expression of corticosteroids is accompanied by body weight loss and reduced food intake
9. Leptin inhibits bone formation through a hypothalamic relay: A central control of bone mass
10. Bone loss and glucocorticoid therapy in patients with respiratory disease
11. Transcriptional regulation of leptin gene promoter in rat
12. A distinct modulation domain in glucocorticoid receptor monomers in the repression of activity of the transcription factor AP-1
13. A new method for the model-independent assessment of thickness in three-dimensional images
14. Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: Potential paracrine mechanisms of glucocorticoid-induced osteoporosis
15. Relationship between serum leptin level and regional bone mineral density, bone metabolic markers in healthy women
16. Increased osteoclast development after estrogen loss: Mediation by interleukin-6
17. Linkage of decreased bone mass with impaired osteoblastogenesis in a murine model of accelerated senescence
18. Circadian variation of serum leptin in healthy and diabetic men
19. Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene
20. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis
21. An update on glucocorticoid induced osteoporosis
22. Skeletal response to corticosteroid deficiency and excess in growing male rats
23. Glucocorticoid Effects on NF-κB binding in the transcription of the ICAM-1 gene
24. Systemic adverse effects of inhaled corticosteroid therapy
25. Genetic variability of new bone induction in mice
26. CBP (CREB binding protein) integrates NF-κB (nuclear factor-κB) and glucocorticoid receptor physical interactions and antagonism
27. Stimulation of bone formation in vitro and in rodents by statins
28. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development
29. Bone histomorphometry: Standardization of nomenclature, symbols and units
30. Role of lipids in osteoporosis
31. Serum leptin levels are associated with bone mass in nonobese women
32. Cortisol inhibits the differentiation and apoptosis of osteoblasts in culture
33. Leptin is expressed in and secreted from primary cultures of human osteoblasts and promotes bone mineralization
34. Stimulation of transcription in vitro from a liver-specific promoter by human glucocorticoid receptor (hGRa)
35. Prednisolone alone, or in combination with estrogen or dietary calcium deficiency or immobilization, inhibits bone formation but does not induce bone loss in mature rats
36. Adverse effects of corticosteroids on the cardiovascular system
37. Evaluation of apoptosis and the glucocorticoid receptor in the cartilage growth plate and metaphyseal bone cells of rats after high-dose treatment with corticosterone
38. Compactin and simvastatin, but not pravastatin, induce bone morphogenetic protein-2 in human osteosarcoma cells
39. Identification and expression cloning of a leptin receptor, OB-R
40. Leptin acts on human marrow stromal cells to enhance differentiation to osteoblast and to inhibit differentiation to adipocytes
41. Public health impact of adverse bone effects of oral corticosteroids
42. Fat conversion of femoral marrow in glucocorticoid-treated patients
43. The effects of androgen deficiency on murine bone remodeling and bone mineral density are mediated via cells of the osteoblastic lineage
44. Inhibition ofosteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids
45. Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice
46. Positional cloning of the mouse obese gene and its human homologue